PRELIMINARY TRIAL OF 9-HYDROXY-2-METHYL ELLIPTICINIUM (NSC 264-137) IN ADVANCED HUMAN CANCERS

被引：118

作者：

JURET, P

TANGUY, A

GIRARD, A

LETALAER, JY

ABBATUCCI, JS

DATXUONG, N

LEPECQ, JB

PAOLETTI, C

机构：

[1] CNRS, INST CHIM SUBST NAT, F-91190 GIF SUR YVETTE, FRANCE

[2] INST GUSTAVE ROUSSY, CHIMOTHERAPIE EXPT LAB, F-94800 VILLEJUIF, FRANCE

来源：

EUROPEAN JOURNAL OF CANCER | 1978年 / 14卷 / 02期

关键词：

D O I：

10.1016/0014-2964(78)90180-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：205 / 206

页数：2

共 7 条

[1] METHOXY-9-ELLIPTICINE LACTATE IN REFRACTORY ACUTE MYELOID LEUKEMIA [J].

ANSARI, BM ;

THOMPSON, EN .

POSTGRADUATE MEDICAL JOURNAL, 1975, 51 (592) :103-105

[2] SYNTHESIS OF TUMOUR-INHIBITORY ALKALOIDS ELLIPTICINE 9-METHOXYELLIPTICINE AND RELATED PYRIDO[4,3-B]CARBAZOLES [J].

DALTON, LK ;

DEMERAC, S ;

ELMES, BC ;

LODER, JW ;

SWAN, JM ;

TEITEI, T .

AUSTRALIAN JOURNAL OF CHEMISTRY, 1967, 20 (12) :2715-&

[3] NEW DNA INTERCALATING DRUG - METHOXY-9-ELLIPTICINE [J].

FESTY, B ;

POISSON, J ;

PAOLETTI, C .

FEBS LETTERS, 1971, 17 (02) :321-+

[4]

LEPECQ JB, 1975, CR ACAD SCI D NAT, V281, P1365

[5] NEW ANTITUMORAL AGENT - 9-HYDROXYELLIPTICINE - POSSIBILITY OF A RATIONAL DESIGN OF ANTI-CANCEROUS DRUGS IN SERIES OF DNA INTERCALATING DRUGS [J].

LEPECQ, JB ;

NGUYENDANGHUNG ;

GOSSE, C ;

PAOLETTI, C .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (12) :5078-5082

[6]

LEPECQ JB, 1976, CANCER RES, V36, P3067

[7]

MATHE G, 1970, EUR J CLIN BIOL RES, V15, P541

← 1 →